Virbagen canis B Suspension for injection for dogs
Virbagen canis B Suspension for injection for dogs
Authorised
- Borreliella afzelii, Inactivated
- Borreliella garinii, Inactivated
Product identification
Medicine name:
Virbagen canis B Suspension for injection for dogs
Virbagen canis B
Active substance:
- Borreliella afzelii, Inactivated
- Borreliella garinii, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Borreliella afzelii, Inactivated1.00relative unit(s)1.00millilitre(s)
-
Borreliella garinii, Inactivated1.00relative unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AB04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- (ID4): 1 Box with 20 Bottle (Glass) with 1 millilitre(s) (20 millilitre(s))
- (ID5): 1 Box with 50 Bottle (Glass) with 1 millilitre(s) (50 millilitre(s))
- (ID1): 1 Box with 2 Bottle (Glass) with 1 millilitre(s) (2 millilitre(s))
- (ID2): 1 Box with 5 Bottle (Glass) with 1 millilitre(s) (5 millilitre(s))
- (ID6): 1 Box with 100 Bottle (Glass) with 1 millilitre(s) (100 millilitre(s))
- (ID3): 1 Box with 10 Bottle (Glass) with 1 millilitre(s) (10 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac Tierarzneimittel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- PEI.V.11433.01.1
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0250/001
Concerned member states:
-
Austria
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 11/02/2022
How useful was this page?: